However, IDO1 was also reported to be related to poor prognosis in some cancer and used as a checkpoint by tumors to escape immune surveillance (Ino, 2011; Tsai et al., 2019; Zhang et al., 2019; Steeneck et al., 2020). Here, IDO1 is linked to cancer.